Intra-Cellular Therapies, Inc. ITCI
131.87 0.00 0.00%
At close · Apr 2
52-week range unavailable
- YTD
- +57.89%
- 1 year
- +97.80%
- Open
- 131.87
- Prev close
- 131.87
- Mkt cap
- 14.05B
- Vol
- 16.04M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 131.87
- High
- 131.87
- Forward P/E
- 507.19
- Beta
- 0.46
- Short ratio
- 1.20
- Inst. own
- 96.45%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 129.34
- 200-d avg
- 93.12
- 1y target
- 132.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for ITCI has not been loaded yet. Try again in a moment.
Altman Z-Score
38.03 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -116×
P/S 12.7×
P/B 7.5×
P/FCF -117×
EV/EBITDA -71.6×
EV/Sales 12.2×
FCF Yield -0.9%
Gross Margin 91.6%
Operating Margin -17.1%
Net Margin -11.0%
ROE -6.5%
ROIC -10.0%
ROA -5.5%
Revenue 46.6%
Operating Income 26.8%
EPS (diluted) 50.7%
Free Cash Flow 40.9%
Current Ratio 6.4×
Quick Ratio 6.2×
Debt / Equity 0.0×
Net Debt / EBITDA 2.5×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2024-12-31